Cargando…

Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells

OBJECTIVE: To investigate if recurrent autoimmunity explained hyperglycemia and C-peptide loss in three immunosuppressed simultaneous pancreas-kidney (SPK) transplant recipients. RESEARCH DESIGN AND METHODS: We monitored autoantibodies and autoreactive T-cells (using tetramers) and performed biopsy....

Descripción completa

Detalles Bibliográficos
Autores principales: Vendrame, Francesco, Pileggi, Antonello, Laughlin, Elsa, Allende, Gloria, Martin-Pagola, Ainhoa, Molano, R. Damaris, Diamantopoulos, Stavros, Standifer, Nathan, Geubtner, Kelly, Falk, Ben A., Ichii, Hirohito, Takahashi, Hidenori, Snowhite, Isaac, Chen, Zhibin, Mendez, Armando, Chen, Linda, Sageshima, Junichiro, Ruiz, Phillip, Ciancio, Gaetano, Ricordi, Camillo, Reijonen, Helena, Nepom, Gerald T., Burke, George W., Pugliese, Alberto
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844842/
https://www.ncbi.nlm.nih.gov/pubmed/20086230
http://dx.doi.org/10.2337/db09-0498
_version_ 1782179341110607872
author Vendrame, Francesco
Pileggi, Antonello
Laughlin, Elsa
Allende, Gloria
Martin-Pagola, Ainhoa
Molano, R. Damaris
Diamantopoulos, Stavros
Standifer, Nathan
Geubtner, Kelly
Falk, Ben A.
Ichii, Hirohito
Takahashi, Hidenori
Snowhite, Isaac
Chen, Zhibin
Mendez, Armando
Chen, Linda
Sageshima, Junichiro
Ruiz, Phillip
Ciancio, Gaetano
Ricordi, Camillo
Reijonen, Helena
Nepom, Gerald T.
Burke, George W.
Pugliese, Alberto
author_facet Vendrame, Francesco
Pileggi, Antonello
Laughlin, Elsa
Allende, Gloria
Martin-Pagola, Ainhoa
Molano, R. Damaris
Diamantopoulos, Stavros
Standifer, Nathan
Geubtner, Kelly
Falk, Ben A.
Ichii, Hirohito
Takahashi, Hidenori
Snowhite, Isaac
Chen, Zhibin
Mendez, Armando
Chen, Linda
Sageshima, Junichiro
Ruiz, Phillip
Ciancio, Gaetano
Ricordi, Camillo
Reijonen, Helena
Nepom, Gerald T.
Burke, George W.
Pugliese, Alberto
author_sort Vendrame, Francesco
collection PubMed
description OBJECTIVE: To investigate if recurrent autoimmunity explained hyperglycemia and C-peptide loss in three immunosuppressed simultaneous pancreas-kidney (SPK) transplant recipients. RESEARCH DESIGN AND METHODS: We monitored autoantibodies and autoreactive T-cells (using tetramers) and performed biopsy. The function of autoreactive T-cells was studied with in vitro and in vivo assays. RESULTS: Autoantibodies were present pretransplant and persisted on follow-up in one patient. They appeared years after transplantation but before the development of hyperglycemia in the remaining patients. Pancreas transplant biopsies were taken within ∼1 year from hyperglycemia recurrence and revealed β-cell loss and insulitis. We studied autoreactive T-cells from the time of biopsy and repeatedly demonstrated their presence on further follow-up, together with autoantibodies. Treatment with T-cell–directed therapies (thymoglobulin and daclizumab, all patients), alone or with the addition of B-cell–directed therapy (rituximab, two patients), nonspecifically depleted T-cells and was associated with C-peptide secretion for >1 year. Autoreactive T-cells with the same autoantigen specificity and conserved T-cell receptor later reappeared with further C-peptide loss over the next 2 years. Purified autoreactive CD4 T-cells from two patients were cotransplanted with HLA-mismatched human islets into immunodeficient mice. Grafts showed β-cell loss in mice receiving autoreactive T-cells but not control T-cells. CONCLUSIONS: We demonstrate the cardinal features of recurrent autoimmunity in three such patients, including the reappearance of CD4 T-cells capable of mediating β-cell destruction. Markers of autoimmunity can help diagnose this underappreciated cause of graft loss. Immune monitoring during therapy showed that autoimmunity was not resolved by the immunosuppressive agents used.
format Text
id pubmed-2844842
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-28448422011-04-01 Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells Vendrame, Francesco Pileggi, Antonello Laughlin, Elsa Allende, Gloria Martin-Pagola, Ainhoa Molano, R. Damaris Diamantopoulos, Stavros Standifer, Nathan Geubtner, Kelly Falk, Ben A. Ichii, Hirohito Takahashi, Hidenori Snowhite, Isaac Chen, Zhibin Mendez, Armando Chen, Linda Sageshima, Junichiro Ruiz, Phillip Ciancio, Gaetano Ricordi, Camillo Reijonen, Helena Nepom, Gerald T. Burke, George W. Pugliese, Alberto Diabetes Original Article OBJECTIVE: To investigate if recurrent autoimmunity explained hyperglycemia and C-peptide loss in three immunosuppressed simultaneous pancreas-kidney (SPK) transplant recipients. RESEARCH DESIGN AND METHODS: We monitored autoantibodies and autoreactive T-cells (using tetramers) and performed biopsy. The function of autoreactive T-cells was studied with in vitro and in vivo assays. RESULTS: Autoantibodies were present pretransplant and persisted on follow-up in one patient. They appeared years after transplantation but before the development of hyperglycemia in the remaining patients. Pancreas transplant biopsies were taken within ∼1 year from hyperglycemia recurrence and revealed β-cell loss and insulitis. We studied autoreactive T-cells from the time of biopsy and repeatedly demonstrated their presence on further follow-up, together with autoantibodies. Treatment with T-cell–directed therapies (thymoglobulin and daclizumab, all patients), alone or with the addition of B-cell–directed therapy (rituximab, two patients), nonspecifically depleted T-cells and was associated with C-peptide secretion for >1 year. Autoreactive T-cells with the same autoantigen specificity and conserved T-cell receptor later reappeared with further C-peptide loss over the next 2 years. Purified autoreactive CD4 T-cells from two patients were cotransplanted with HLA-mismatched human islets into immunodeficient mice. Grafts showed β-cell loss in mice receiving autoreactive T-cells but not control T-cells. CONCLUSIONS: We demonstrate the cardinal features of recurrent autoimmunity in three such patients, including the reappearance of CD4 T-cells capable of mediating β-cell destruction. Markers of autoimmunity can help diagnose this underappreciated cause of graft loss. Immune monitoring during therapy showed that autoimmunity was not resolved by the immunosuppressive agents used. American Diabetes Association 2010-04 2010-01-19 /pmc/articles/PMC2844842/ /pubmed/20086230 http://dx.doi.org/10.2337/db09-0498 Text en © 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Article
Vendrame, Francesco
Pileggi, Antonello
Laughlin, Elsa
Allende, Gloria
Martin-Pagola, Ainhoa
Molano, R. Damaris
Diamantopoulos, Stavros
Standifer, Nathan
Geubtner, Kelly
Falk, Ben A.
Ichii, Hirohito
Takahashi, Hidenori
Snowhite, Isaac
Chen, Zhibin
Mendez, Armando
Chen, Linda
Sageshima, Junichiro
Ruiz, Phillip
Ciancio, Gaetano
Ricordi, Camillo
Reijonen, Helena
Nepom, Gerald T.
Burke, George W.
Pugliese, Alberto
Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells
title Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells
title_full Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells
title_fullStr Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells
title_full_unstemmed Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells
title_short Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells
title_sort recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive cd4 t-cells
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844842/
https://www.ncbi.nlm.nih.gov/pubmed/20086230
http://dx.doi.org/10.2337/db09-0498
work_keys_str_mv AT vendramefrancesco recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT pileggiantonello recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT laughlinelsa recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT allendegloria recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT martinpagolaainhoa recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT molanordamaris recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT diamantopoulosstavros recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT standifernathan recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT geubtnerkelly recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT falkbena recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT ichiihirohito recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT takahashihidenori recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT snowhiteisaac recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT chenzhibin recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT mendezarmando recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT chenlinda recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT sageshimajunichiro recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT ruizphillip recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT cianciogaetano recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT ricordicamillo recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT reijonenhelena recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT nepomgeraldt recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT burkegeorgew recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells
AT pugliesealberto recurrenceoftype1diabetesaftersimultaneouspancreaskidneytransplantationdespiteimmunosuppressionisassociatedwithautoantibodiesandpathogenicautoreactivecd4tcells